CACCIAPAGLIA, FRANCESCO

CACCIAPAGLIA, FRANCESCO  

Mostra records
Risultati 1 - 20 di 20 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 1-gen-2022 Venerito, V.; Angelini, O.; Fornaro, M.; Cacciapaglia, F.; Lopalco, G.; Iannone, F.
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 1-gen-2016 Lopalco, G.; Lucherini, O. M.; Cantarini, L.; Lopalco, A.; Vitale, Antonio; Venerito, V.; Chialà, Angela; Fornaro, M.; Anelli, M. G.; Scioscia, C.; Cacciapaglia, F.; Natuzzi, D.; Lapadula, G.; Iannone, Florenzo
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 1-gen-2015 Lopalco, G.; Lucherini, O. M.; Cantarini, L.; Vitale, Antonio; Talarico, R.; Giannini, Margherita; Scioscia, C.; Anelli, M. G.; Cacciapaglia, F.; Natuzzi, D.; Bizzoca, R.; Perniola, S.; Lapadula, G.; Iannone, Florenzo
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 1-gen-2015 Cacciapaglia, F.; Anelli, Maria Grazia.; Rinaldi, Angela; Scioscia, C.; Lopalco, G.; Covelli, Michele; Iannone, Florenzo; Lapadula, G.
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 1-gen-2018 Lopalco, G.; Venerito, V.; Cantarini, L.; Emmi, G.; Salaffi, F.; Tafuri, S.; Bianchi, F. P.; Di Carlo, M.; Gentileschi, S.; Di Scala, G.; Nivuori, M.; Perniola, S.; Fornaro, M.; Anelli, M. G.; Cacciapaglia, F.; Scioscia, C.; Fabiani, C.; Galeazzi, M.; Lapadula, G.; Iannone, Florenzo
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis 1-gen-2021 Iannone, F.; Praino, E.; Rotondo, C.; Natuzzi, D.; Bizzoca, R.; Lacarpia, N.; Fornaro, M.; Cacciapaglia, F.
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 1-gen-2022 Cacciapaglia, F.; Venerito, V.; Stano, S.; Fornaro, M.; Lopalco, G.; Iannone, F.
Complete Hydatidiform Mole Mimicking Sacroiliitis 1-gen-2021 Arezzo, F.; Venerito, V.; Fornaro, M.; Cacciapaglia, F.; Lopalco, G.; Iannone, F.
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 1-gen-2020 Fornaro, M.; Coladonato, L.; Venerito, V.; Cacciapaglia, F.; Lopalco, G.; Iannone, F.
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 1-gen-2021 Fornaro, M.; Righetti, G.; Abbruzzese, A.; Lopalco, G.; Cacciapaglia, F.; Anelli, M. G.; Venerito, V.; Iannone, F.
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 1-gen-2022 Venerito, V.; Stefanizzi, P.; Fornaro, M.; Cacciapaglia, F.; Tafuri, S.; Perniola, S.; Iannone, F.; Lopalco, G.
Letters to the editors 1-gen-2021 Cacciapaglia, F.; Renna, D.; Fornaro, M.; Venerito, V.; Lopalco, G.; Iannone, F.
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 1-gen-2013 Cacciapaglia, F; Anelli, Mg; Rinaldi, Angela; Serafino, L; Coladonato, L; Covelli, Michele; Scioscia, C; Iannone, Florenzo; Lapadula, G
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 1-gen-2022 Barone, M.; Venerito, V.; Paolillo, R.; Emmi, G.; Fornaro, M.; Cacciapaglia, F.; Cantarini, L.; Di Leo, A.; Iannone, F.; Lopalco, G.
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 1-gen-2018 Lopriore, S.; Cacciapaglia, F.; Perniola, S.; Anelli, M. G.; Lopalco, G.; Scioscia, C.; Coladonato, L.; Laselva, G.; Lapadula, G.; Iannone, Florenzo.
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 1-gen-2023 Fornaro, M; Girolamo, F; Cacciapaglia, F; Carabellese, G; Bizzoca, R; Scioscia, C; Coladonato, L; Lopalco, G; Ruggieri, M; Mastrapasqua, M; Fari, G; D’Abbicco, D; Iannone, F
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases 1-gen-2022 Fornaro, M.; Venerito, V.; Iannone, F.; Cacciapaglia, F.
Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast 1-gen-2020 Venerito, V; Natuzzi, D; Bizzoca, R; Lacarpia, N; Cacciapaglia, F; Lopalco, G; Iannone, F
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 1-gen-2023 Cacciapaglia, F.; Airo, P.; Fornaro, M.; Trerotoli, P.; De Lorenzis, E.; Corrado, A.; Lazzaroni, M. G.; Natalello, G.; Montini, F.; Altomare, A.; Urso, L.; Verardi, L.; Bosello, S. L.; Cantatore, F. P.; Iannone, F.
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 1-gen-2018 Cacciapaglia, F.; Fornaro, M.; Renna, D.; Cafarelli, F.; Lopalco, G.; Anelli, M. G.; Scioscia, C.; Lapadula, G.; Iannone, Florenzo